Monopar Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:MNPR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
26 Dec 25	BuyUS$104,925	Quan Vu	Individual	1,500	US$69.95
18 Dec 25	SellUS$343,889	Arthur Klausner	Individual	5,121	US$68.09
24 Sep 25	SellUS$34,999,957	Tactic Pharma LLC	Company	550,229	US$63.61
02 Apr 25	SellUS$1,166,690	Tactic Pharma LLC	Company	33,334	US$35.00

Insider Trading Volume

Insider Buying: MNPR insiders have sold more shares than they have bought in the past 3 months.

Ownership Breakdown

What is the ownership structure of MNPR?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	0	0%
General Public	286,573	4.29%
Individual Insiders	459,286	6.87%
Public Companies	522,667	7.82%
Hedge Funds	639,467	9.57%
VC/PE Firms	667,207	9.98%
Institutions	4,107,384	61.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 90.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.7%	Janus Henderson Group plc	1,317,410	US$71.4m	2.33%	0.03%
9.98%	RA Capital Management, L.P.	667,207	US$36.2m	30.5%	0.38%
9.57%	Adage Capital Management, L.P.	639,467	US$34.7m	-2.99%	0.05%
7.82%	AstraZeneca PLC	522,667	US$28.3m	34.9%	0.95%
4.87%	Saturn V Capital Management LP	325,701	US$17.7m	110%	3.01%
4.4%	The Vanguard Group, Inc.	293,816	US$15.9m	41.1%	no data
3.81%	BlackRock, Inc.	254,857	US$13.8m	25.1%	no data
3.5%	ADAR1 Capital Management, LLC	233,908	US$12.7m	79.9%	0.94%
3.38%	Wellington Management Group LLP	226,068	US$12.3m	-2.33%	no data
3.18%	Artal Group S.A.	212,298	US$11.5m	0%	0.24%
2.55%	Deerfield Management Company, L.P.	170,558	US$9.2m	6.76%	0.12%
2.22%	Chandler Robinson	148,533	US$8.1m	73.3%	no data
2.12%	TCG Crossover Management, LLC	141,915	US$7.7m	-7.25%	0.24%
1.58%	Michael Brown	105,751	US$5.7m	124%	no data
1.48%	Geode Capital Management, LLC	99,007	US$5.4m	16.5%	no data
1.43%	Deep Track Capital, LP	95,408	US$5.2m	0%	0.11%
1.4%	Diane Hendricks	93,750	US$5.1m	0%	no data
1.35%	Vivo Capital, LLC	90,500	US$4.9m	0%	0.29%
1.26%	State Street Global Advisors, Inc.	83,989	US$4.6m	16.3%	no data
1.15%	Millennium Management LLC	76,674	US$4.2m	945%	no data
0.97%	BNY Asset Management	64,857	US$3.5m	278%	no data
0.76%	Andrew Cittadine	50,726	US$2.8m	5.05%	no data
0.6%	Alyeska Investment Group, L.P.	40,000	US$2.2m	227%	0.01%
0.5%	Driehaus Capital Management LLC	33,715	US$1.8m	-47.8%	0.01%
0.49%	Neuberger Berman Investment Advisers LLC	32,547	US$1.8m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/18 15:01
End of Day Share Price	2026/02/18 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Monopar Therapeutics Inc. is covered by 17 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Etzer Darout	Barclays
Brian Kemp Dolliver	Brookline Capital Markets
Suranjit Mukherjee	BTIG